213 completed. 213 Phase 2, 43 Phase 1, 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 213 | Completed 213 |
| Phase 1 | 43 | Completed 43 |
| Phase 3 | 5 | Completed 5 |
Follow Rituxan: new trials by email Literature Review of Rituxan trials Research Report on Rituxan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituxmab Versus IL-6 in Treating ILD Rituximab, IL6 inhibitor - Interstitial Lung Disease, Scleroderma | Phase 2 / Phase 3 | Completed | Assiut University | 60 | 2021-12-01 | 2023-11-15 |
| Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi Rituximab, Etoposide - Multicentric Castleman Disease | Phase 2 | Completed | UNC Lineberger Comprehensive Cancer Center | 15 | 2021-06-22 | 2026-07-30 |
| Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age Venetoclax, Bendamustine, Rituximab - Mantle Cell Lymphoma | Phase 2 | Completed | PrECOG, LLC. | 33 | 2020-01-13 | 2025-08-11 |
| A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL Pirtobrutinib, Venetoclax, Rituximab - Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia | Phase 1 / Phase 2 | Completed | Loxo Oncology, Inc. | 803 | 2019-03-15 | 2026-01-27 |
| Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma Bendamustine, Rituximab, Acalabrutinib - Mantle Cell Lymphoma | Phase 2 | Completed | Washington University School of Medicine | 13 | 2018-11-29 | 2026-04-21 |
| Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia Bendamustine, Venetoclax, Rituximab - Chronic Lymphocytic Leukemia | Phase 2 | Completed | Nicole Lamanna | 42 | 2018-11-12 | 2026-10-07 |
| Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma Anti-Thymocyte Globulin, Busulfan, Clofarabine - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia | Phase 2 | Completed | M.D. Anderson Cancer Center | 6 | 2017-10-13 | 2023-10-11 |
| Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma Autologous Hematopoietic Stem Cell Transplantation, Carmustine, Cord Blood-derived Expanded Allogeneic Natural Killer Cells - Mantle Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 22 | 2017-10-10 | 2023-02-16 |
| Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder Allogeneic LMP1/LMP2-Specific Cytotoxic T-Lymphocytes, Rituximab - EBV-Related Post-Transplant Lymphoproliferative Disorder, Monomorphic Post-Transplant Lymphoproliferative Disorder | Phase 2 | Completed | Children's Oncology Group | 18 | 2017-03-22 | 2026-01-26 |
| Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Cyclophosphamide, Dasatinib, Doxorubicin - Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | Phase 2 | Completed | University of Washington | 54 | 2017-02-23 | 2022-07-13 |
| A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) Rituximab (RTX), Tafasitamab, Bendamustine (BEN) - Diffuse Large B-cell Lymphoma | Phase 2 / Phase 3 | Completed | Incyte Corporation | 453 | 2016-11-28 | 2025-07-17 |
| Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma Ibrutinib, Laboratory Biomarker Analysis, Lenalidomide - Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 48 | 2016-04-11 | 2024-09-24 |
| Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide - Diffuse Large B-Cell Lymphoma Unclassifiable | Phase 2 | Completed | M.D. Anderson Cancer Center | 60 | 2016-03-29 | 2024-03-13 |
| Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Rituximab, Conditioning chemotherapy, TMS - Myelodysplastic Syndromes, Hodgkin's Lymphoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 34 | 2015-09-24 | 2025-09-30 |
| Rituximab and Belimumab for Lupus Nephritis Rituximab, Cyclophosphamide, Prednisone - Lupus Nephritis | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 43 | 2015-07-09 | 2020-12-01 |
| Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients Lirilumab, Rituximab - Leukemia, Chronic Lymphocytic Leukemia | Phase 2 | Completed | M.D. Anderson Cancer Center | 7 | 2015-06-23 | 2020-05-28 |
| Belimumab Impacting Transplant Eligibility belimumab, Bortezomib, Rituximab - Renal Transplant Rejection | Phase 1 / Phase 2 | Completed | E. Steve Woodle | 11 | 2015-06-01 | 2019-04-22 |
| Brentuximab for Newly Diagnosed Hodgkin Disease Brentuximab Vedotin, Doxorubicin, Vincristine - Hodgkin Lymphoma | Phase 2 | Completed | Mitchell Cairo | 40 | 2015-05-01 | 2023-10-26 |
| Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia Ixazomib, Dexamethasone, Rituximab - Waldenstrom's Macroglobulinemia | Phase 2 | Completed | Dana-Farber Cancer Institute | 26 | 2015-04-01 | 2020-09-02 |
| Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma Carfilzomib, Rituximab, Cyclophosphamide - Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma | Phase 1 / Phase 2 | Completed | Case Comprehensive Cancer Center | 48 | 2015-01-28 | 2024-05-29 |
Showing 20 of 213. Sign in to see all of them.
Lymphoma (61) · Leukemia, Lymphocytic, Chronic, B-Cell (53) · Lymphoma, Mantle-Cell (53) · Lymphoma, Non-Hodgkin (49) · Lymphoma, Follicular (42) · Lymphoma, Large B-Cell, Diffuse (40) · Leukemia (26) · Lymphoma, B-Cell, Marginal Zone (25) · Hodgkin Disease (22) · Waldenstrom Macroglobulinemia (22) · Burkitt Lymphoma (21) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (20) · Lymphoma, Large-Cell, Immunoblastic (15) · Lymphoma, B-Cell (13) · Recurrence (10)
M.D. Anderson Cancer Center (53) · National Cancer Institute (NCI) (22) · Fred Hutchinson Cancer Center (7) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (6) · Dana-Farber Cancer Institute (5) · University of Nebraska (5) · City of Hope Medical Center (4) · SCRI Development Innovations, LLC (4) · Weill Medical College of Cornell University (4) · Hoffmann-La Roche (3) · Massachusetts General Hospital (3) · Mayo Clinic (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Northwestern University (3) · University of Arizona (3)
United States (201) · Canada (10) · United Kingdom (9) · Italy (8) · France (6) · Germany (6) · Australia (5) · Spain (5) · Belgium (4) · Czechia (4) · Israel (4) · Poland (4) · Sweden (4) · Austria (2) · Brazil (2)
Alessandra Ferrajoli, MD (3) · Daniel O. Persky, MD (3) · Felipe Samaniego, MD (3) · Issa F. Khouri, MD (3) · Izidore S. Lossos, MD (3) · Julie M Vose, MD (3) · Ajay Gopal (2) · Anas Younes, MD (2) · Andrew M. Evens, DO, MS (2) · Chitra M. Hosing, MD (2) · Christos E. Emmanouilides, MD (2) · David Maloney (2) · E. Steve Woodle, MD (2) · Elias Jabbour, MD (2)
PMID 23834234, PMID 24224624, PMID 30125215, PMID 33735476, PMID 12353309, PMID 12907446, PMID 15389904, PMID 18713945, PMID 20023215, PMID 20038221, PMID 20039397, PMID 20039413, PMID 20058208, PMID 20142586, PMID 20223728, PMID 20647199, PMID 20956803, PMID 21098574, PMID 21239695, PMID 21440503, PMID 21478218, PMID 21508413, PMID 21756035, PMID 22269862, PMID 22282683, PMID 22357140, PMID 22371887, PMID 22563089, PMID 22586182, PMID 22677155, PMID 22734071, PMID 22835045, PMID 22975753, PMID 23124321, PMID 23124935, PMID 23279219, PMID 23514433, PMID 23547837, PMID 23574119, PMID 23592273, PMID 23656665, PMID 23753030, PMID 23754238, PMID 23902481, PMID 23940282, PMID 23955074, PMID 24048792, PMID 24332512, PMID 24458437, PMID 24516013
P30CA015704 (6), P30CA006973 (5), P30CA016672 (3), P30CA023074 (3), P30CA036727 (3), P50CA096888 (3), U10CA025224 (3), U10CA031946 (3), U10CA180821 (3), 2014 (2), P01CA030206 (2), P30CA033572 (2), U01CA070019 (2), U10CA021115 (2), U10CA032102 (2)